Literature DB >> 32476457

Estimating Increased EGP During Stress Response in Critically Ill Patients.

Jennifer J Ormsbee1, Jennifer L Knopp1, J Geoffrey Chase1.   

Abstract

BACKGROUND: Stress-induced hyperglycemia is frequently experienced by critically ill patients and the use of glycemic control (GC) has been shown to improve patient outcomes. For model-based approaches to GC, it is important to understand and quantify model parameter assumptions. This study explores endogenous glucose production (EGP) and the use of a population-based parameter value in the intensive care unit context.
METHOD: Hourly insulin sensitivity (SI) was fit to clinical data from 145 patients on the Specialized Relative Insulin and Nutrition Titration GC protocol for at least 24 hours. Constraint of SI at a lower bound was used to explore likely EGP variability due to stress response. Minimum EGP was estimated during times when the model SI was constrained, and time and duration of events were examined.
RESULTS: Constrained events occur for 1.6% of patient hours. About 70% of constrained events occur in the first 12 hours and most events (~80%) occur when there is no exogenous nutrition given. Enhanced EGP values ranged from 1.16 mmol/min (current population value) to 2.75 mmol/min, with most being below 1.5 mmol/min (21% increase).
CONCLUSION: The frequency of constrained events is low and the current population value of 1.16 mmol/min is sufficient for more than 98% of patient hours, however, some patients experience significantly raised EGP probably due to an extreme stress response early in patient stay.

Entities:  

Keywords:  EGP; critical illness; endogenous glucose production; glycemic control; hyperglycemia; insulin resistance; insulin sensitivity; physiological stress

Year:  2020        PMID: 32476457      PMCID: PMC8258514          DOI: 10.1177/1932296820922842

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  62 in total

Review 1.  Alterations in fuel metabolism in critical illness: hyperglycaemia.

Authors:  B A Mizock
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2001-12       Impact factor: 4.690

Review 2.  Molecular mechanisms behind clinical benefits of intensive insulin therapy during critical illness: glucose versus insulin.

Authors:  Ilse Vanhorebeek; Lies Langouche
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2009-12

3.  Evolution of insulin sensitivity and its variability in out-of-hospital cardiac arrest (OHCA) patients treated with hypothermia.

Authors:  Azurahisham Sah Pri; J Geoffrey Chase; Christopher G Pretty; Geoffrey M Shaw; Jean-Charles Preiser; Jean-Louis Vincent; Mauro Oddo; Fabio S Taccone; Sophie Penning; Thomas Desaive
Journal:  Crit Care       Date:  2014-10-28       Impact factor: 9.097

4.  Design and clinical pilot testing of the model-based dynamic insulin sensitivity and secretion test (DISST).

Authors:  Thomas F Lotz; J Geoffrey Chase; Kirsten A McAuley; Geoffrey M Shaw; Paul D Docherty; Juliet E Berkeley; Sheila M Williams; Christopher E Hann; Jim I Mann
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

Review 5.  Glycemic control in the critically ill: What have we learned since NICE-SUGAR?

Authors:  James Stephen Krinsley
Journal:  Hosp Pract (1995)       Date:  2015

6.  Effect of an intensive glucose management protocol on the mortality of critically ill adult patients.

Authors:  James Stephen Krinsley
Journal:  Mayo Clin Proc       Date:  2004-08       Impact factor: 7.616

7.  Endogenous Glucose Production and Hormonal Changes in Response to Canagliflozin and Liraglutide Combination Therapy.

Authors:  Robert Martinez; Hussein Al-Jobori; Ali M Ali; John Adams; Muhammad Abdul-Ghani; Curtis Triplitt; Ralph A DeFronzo; Eugenio Cersosimo
Journal:  Diabetes       Date:  2018-03-30       Impact factor: 9.461

8.  Benefits and risks of tight glucose control in critically ill adults: a meta-analysis.

Authors:  Renda Soylemez Wiener; Daniel C Wiener; Robin J Larson
Journal:  JAMA       Date:  2008-08-27       Impact factor: 56.272

9.  Variability of insulin sensitivity during the first 4 days of critical illness: implications for tight glycemic control.

Authors:  Christopher G Pretty; Aaron J Le Compte; J Geoffrey Chase; Geoffrey M Shaw; Jean-Charles Preiser; Sophie Penning; Thomas Desaive
Journal:  Ann Intensive Care       Date:  2012-06-15       Impact factor: 6.925

10.  Traversing the valley of glycemic control despair.

Authors:  J Geoffrey Chase; Jennifer L Dickson
Journal:  Crit Care       Date:  2017-09-07       Impact factor: 9.097

View more
  2 in total

1.  Variability in Estimated Modelled Insulin Secretion.

Authors:  Jennifer J Ormsbee; Hannah J Burden; Jennifer L Knopp; J Geoffrey Chase; Rinki Murphy; Peter R Shepherd; Troy Merry
Journal:  J Diabetes Sci Technol       Date:  2021-02-15

2.  Estimating Enhanced Endogenous Glucose Production in Intensive Care Unit Patients with Severe Insulin Resistance.

Authors:  Anane Yahia; Ákos Szlávecz; Jennifer L Knopp; Normy Norfiza Abdul Razak; Asma Abu Samah; Geoff Shaw; J Geoffrey Chase; Balazs Benyo
Journal:  J Diabetes Sci Technol       Date:  2021-06-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.